Mixed-effects beta regression for modeling continuous bounded outcome scores using NONMEM when data are not on the boundaries

Journal of Pharmacokinetics and Pharmacodynamics

Volumn 40, Issue 4, 2013, Pages 537-544

  Xu, Xu Steven ^a   Samtani, Mahesh N ^a   Dunne, Adrian ^b   Nandy, Partha ^a   Vermeulen, An ^b   De Ridder, Filip ^b  

^a JANSSEN RESEARCH AND DEVELOPMENT   (United States)

^b JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ALZHEIMER DISEASE; ARTICLE; COMPUTER PROGRAM; CONTINUOUS BOUNDED OUTCOME SCORE; INTERMETHOD COMPARISON; KERNEL METHOD; MONTE CARLO METHOD; PREDICTION; PRIORITY JOURNAL; RANDOM SAMPLE; REGRESSION ANALYSIS; SCORING SYSTEM; SIMULATION;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; COMPUTER SIMULATION; DISEASE PROGRESSION; HUMANS; MIDDLE AGED; MODELS, STATISTICAL; MONTE CARLO METHOD; NORMAL DISTRIBUTION; REGRESSION ANALYSIS;

EID: 84881188422     PISSN: 1567567X     EISSN: 15738744     Source Type: Journal    
DOI: 10.1007/s10928-013-9318-0     Document Type: Article

References (26)

1. Frisoni GB, Caroli A (2007) Neuroimaging outcomes for clinical trials. J Nutr Health Aging 11(4):348-352
2. Gelinas I et al (1999) Development of a functional measure for persons with Alzheimer's disease: the disability assessment for dementia. Am J Occup Ther 53(5):471-481
3. ® global forum proceedings, Paper 335, pp 1-12
4. Cribari-Neto F, Zeileis A (2010) Beta regression in R. J Stat Softw 34(2):1-24
5. Ferrari SP, Cribari-Neto F (2004) Beta regression for modelling rates and proportions. J Appl Stat 31(7):799-815
6. Smithson M, Verkuilen J (2006) A better lemon squeezer? maximum-likelihood regression with beta-distributed dependent variables. Psychol Methods 11(1):54-71
7. Rogers JA et al (2011) A longitudinal dose-response model for the progression of Alzheimers disease, based on a combination of summary-level and patient-level data. In: 4th annual bayesian biostatistics conference, Houston
8. Rogers JA et al (2012) Combining patient-level and summary-level data for Alzheimer's disease modeling and simulation: a beta regression meta-analysis. J Pharmacokinet Pharmacodyn 39(5):479-498
9. Verkuilen J, Smithson M (2012) Mixed and mixture regression models for continuous bounded responses using the beta distribution. J Educ Behav Stat 37(1):82-113
10. Nemes G (2010) New asymptotic expansion for the gamma function. Arch Math 95(2):161-169
11. Pregibon D (1980) Goodness of link tests for generalized linear models. Appl Stat 29(1):15-24
12. Chen KF, Wu JW (1994) Testing goodness of fit for a parametric family of link functions. J Am Stat Assoc 89(426):657-664
13. McCullagh P, Nelder JA (1989) Generalized linear models, monographs on statistics and applied probability, vol 37, 2nd edn. Chapman and Hall, New York, p 511
14. Nemes G (2008) New asymptotic expansion for the gamma function. http://dx.doi.org/10.3247/sl2math08.005
15. Samtani MN et al (2012) An improved model for disease progression in patients from the Alzheimer's disease neuroimaging initiative. J Clin Pharmacol 52(5):629-644
16. Ito K et al (2010) Disease progression meta-analysis model in Alzheimer's disease. Alzheimers Dement 6(1):39-53
17. Ito K et al (2011) Disease progression model for cognitive deterioration from Alzheimer's disease neuroimaging initiative database. Alzheimers Dement 7(2):151-160
18. Espinheira PL, Ferrari SLP, Cribari-Neto F (2008) On beta regression residuals. J Appl Stat 35(4):407-419
19. Karlsson MO, Holford N, (2008) A tutorial on visual predictive checks,p 17, Abstr 1434 [ www.page-meeting.org/?abstract=1434 ], PAGE
20. Ospina R, Ferrari SP (2010) Inflated beta distributions. Stat Pap 51:111-126
21. Ospina R, Ferrari SP (2012) A general class of zero-or-one inflated beta regression models. Comput Stat Data Anal 56(6):1609-1623
22. Hutmacher MM et al (2012) Estimating transformations for repeated measures modeling of continuous bounded outcome data. Stat Med 30(9):935-949
23. Ito K, Hutmacher MM, Corrigan BW (2012) Modeling of functional assessment questionnaire (FAQ) as continuous bounded data from the ADNI database. J Pharmacokinet Pharmacodyn 39(6):601-618
24. Molas M, Lesaffre E (2008) A comparison of three random effects approaches to analyze repeated bounded outcome scores with an application in a stroke revalidation study. Stat Med 27(30):6612-6633
25. Hu C et al (2011) Bounded outcome score modeling: application to treating psoriasis with ustekinumab. J Pharmacokinet Pharmacodyn 38(4):497-517
26. Pinheiro JC, Bates DM (1995) Approximations to the log-likelihood function in the nonlinear mixed-effects model. J Comput Graph Stat 4(1):12-35